183 related articles for article (PubMed ID: 7987980)
1. Cellular pharmacology of D-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activity.
Brunn G; Fauq AH; Chow S; Kozikowski AP; Gallegos A; Powis G
Cancer Chemother Pharmacol; 1994; 35(1):71-9. PubMed ID: 7987980
[TBL] [Abstract][Full Text] [Related]
2. D-3-deoxy-3-substituted myo-inositol analogues as inhibitors of cell growth.
Powis G; Aksoy IA; Melder DC; Aksoy S; Eichinger H; Fauq AH; Kozikowski AP
Cancer Chemother Pharmacol; 1991; 29(2):95-104. PubMed ID: 1760864
[TBL] [Abstract][Full Text] [Related]
3. Substrate properties of analogs of myo-inositol.
Moyer JD; Reizes O; Ahir S; Jiang C; Malinowski N; Baker DC
Mol Pharmacol; 1988 Jun; 33(6):683-9. PubMed ID: 2837638
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 3-modified 1D-myo-inositols as inhibitors and substrates of phosphatidylinositol synthase and inhibitors of myo-inositol uptake by cells.
Johnson SC; Dahl J; Shih TL; Schedler DJ; Anderson L; Benjamin TL; Baker DC
J Med Chem; 1993 Nov; 36(23):3628-35. PubMed ID: 8246231
[TBL] [Abstract][Full Text] [Related]
5. The 5-hydroxyl of myo-inositol is essential for uptake into HSDM1C1 mouse fibrosarcoma cells.
Auchus RJ; Wilson DB; Covey DF; Majerus PW
Biochem Biophys Res Commun; 1985 Aug; 130(3):1139-46. PubMed ID: 4026861
[TBL] [Abstract][Full Text] [Related]
6. The uptake of 3H-labelled monodeoxyfluoro-myo-inositols into thymocytes and their incorporation into phospholipid in permeabilized cells.
Offer J; Metcalfe JC; Smith GA
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):553-60. PubMed ID: 8387272
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol synthase of proximal tubule cells.
Galvao C; Shayman JA
Biochim Biophys Acta; 1990 May; 1044(1):34-42. PubMed ID: 2160284
[TBL] [Abstract][Full Text] [Related]
8. Yeast mutant defective in synthesis of phosphatidylinositol. Isolation and characterization of a CDPdiacylglycerol--inositol 3-phosphatidyltransferase Km mutant.
Nikawa J; Yamashita S
Eur J Biochem; 1982 Jul; 125(2):445-51. PubMed ID: 6288375
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by Ca2+ of the incorporation of myo-inositol into phosphatidylinositol.
Egawa K; Takenawa T; Sacktor B
Mol Cell Endocrinol; 1981 Jan; 21(1):29-35. PubMed ID: 6259001
[TBL] [Abstract][Full Text] [Related]
11. Myo-inositol does not modulate PI turnover in MDCK cells under hyperosmolar conditions.
Shayman JA; Wu D
Am J Physiol; 1990 May; 258(5 Pt 2):F1282-7. PubMed ID: 2159718
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol synthetase activities in neuronal nuclei and microsomal fractions isolated from immature rabbit cerebral cortex.
Baker RR; Chang H
Biochim Biophys Acta; 1990 Jan; 1042(1):55-61. PubMed ID: 2153412
[TBL] [Abstract][Full Text] [Related]
13. Studies of inositol analogues as inhibitors of the phosphoinositide pathway, and incorporation of 2-deoxy-2-fluoro-myo-inositol to give analogues of phosphatidylinositol intermediates.
McPhee F; Downes CP; Lowe G
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):407-12. PubMed ID: 1650182
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol:myo-inositol exchange activity in intact nerve endings: substrate and cofactor dependence, nucleotide specificity, and effect on synaptosomal handling of myo-inositol.
Berry G; Yandrasitz JR; Cipriano VM; Hwang SM; Segal S
J Neurochem; 1986 Apr; 46(4):1073-80. PubMed ID: 3005502
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells.
Nakamura J; Del Monte MA; Shewach D; Lattimer SA; Greene DA
Am J Physiol; 1992 Apr; 262(4 Pt 1):E417-26. PubMed ID: 1314495
[TBL] [Abstract][Full Text] [Related]
16. Unimpaired formation of hormone-stimulated inositol trisphosphate in human mesangial cells under hyperglycemic conditions.
Greenberg L; Urbanes AQ; Shayman JA
Biochim Biophys Acta; 1992 Mar; 1138(3):229-35. PubMed ID: 1312360
[TBL] [Abstract][Full Text] [Related]
17. Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy.
Conrad KP; Barrera SA; Friedman PA; Schmidt VM
J Clin Invest; 1991 May; 87(5):1700-9. PubMed ID: 1850759
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone (GnRH) rapidly stimulates the formation of inositol phosphates and diacyglycerol in rat granulosa cells: further evidence for the involvement of Ca2+ and protein kinase C in the action of GnRH.
Davis JS; West LA; Farese RV
Endocrinology; 1986 Jun; 118(6):2561-71. PubMed ID: 3009164
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CDP-DG: inositol transferase by inostamycin.
Imoto M; Taniguchi Y; Umezawa K
J Biochem; 1992 Aug; 112(2):299-302. PubMed ID: 1328172
[TBL] [Abstract][Full Text] [Related]
20. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
